Publication | Open Access

Nicotinamide mononucleotide inhibits post-ischemic NAD+ degradation and dramatically ameliorates brain damage following global cerebral ischemia

Cerebral Vascular RegulationBrain DamageIschemic StrokeReperfusion InjuryMedicinePharmacologyCerebrovascular DiseaseNeuropharmacologyVascular BiologyBrain InjuryNeurologyNeuroprotectionNeuroscienceCerebral Blood FlowGlobal Cerebral IschemiaStrokeIschemic SyndromePost-ischemic Nad+ Degradation